Endoleak after Endovascular Abdominal Aortic Aneurysm Repair Treated by Bilateral Transradial Access: Case Report [0.03%]
经双侧桡动脉途径治疗内脏期腹主动脉瘤修复术后内漏1例报告
Gustavo A Samaja,Heber Tejerina Segovia,José M Escalante et al.
Gustavo A Samaja et al.
The treatment of endovascular leaks after endovascular abdominal aortic repair can be challenging, particularly in patients with a lack of vascular access. We describe the case of a critically ill elderly patient with an endoleak resulting ...
Side Branch is the Main Determinant Factor of Bifurcation Lesion Complexity: Critical Review with a Proposal Based on Single-centre Experience [0.03%]
sidelines决定分叉病变复杂程度的决定性因素：基于单中心经验的评论与建议
Imad Sheiban,Filippo Figini,Valeria Gasparetto et al.
Imad Sheiban et al.
Although bifurcation stenting can be often managed with a simple provisional approach, in some settings, more complex techniques are appropriate. Based on our clinical experience and on data from literature, we propose a simple algorithm th...
Tomoya T Hinohara,Michael J Reardon,Sachin S Goel
Tomoya T Hinohara
Mitral regurgitation (MR) is the most prevalent valvular heart disease globally. Mitral valve surgery is the gold-standard treatment for MR. However, a significant portion of patients with mitral valve disease are at high or prohibitive sur...
XIENCE Implantation Followed By Short Dual Antiplatelet Therapy: 'The New Normal'? [0.03%]
XiENCE植入术后短期双抗治疗：“新常态”?
Niels Mr van der Sangen,Wouter J Kikkert,José Ps Henriques et al.
Niels Mr van der Sangen et al.
The XIENCE family of everolimus-eluting stents ranks among the most used and most widely studied drug-eluting stents worldwide. In patients at high bleeding risk undergoing non-complex percutaneous coronary intervention with these stents, a...
An Update on Drug-eluting Technology in Peripheral Arteries to Treat Peripheral Arterial Disease [0.03%]
外周动脉药物洗脱技术治疗外周动脉疾病进展
Leonardo Marques,Silke Hopf-Jensen,Michael Preiss et al.
Leonardo Marques et al.
For the treatment of peripheral arterial disease, drug-eluting technology is a widely accepted therapeutic option, with significant reduction in intimal hyperplasia and, consequently, use of target lesion revascularization. Nevertheless, th...
The HEP-COVID Trial [0.03%]
HEP-COVID试验
Alex C Spyropoulos
Alex C Spyropoulos
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Left Main Revascularisation [0.03%]
左主干血运重建的经皮冠状动脉介入治疗与冠脉旁路移植术对比研究
Timir Kumar Paul
Timir Kumar Paul
Management of Coronary Artery Disease in the Setting of Transcatheter Aortic Valve Replacement [0.03%]
经导管主动脉瓣置换术后的冠状动脉疾病的处理策略
Natraj Katta,J Dawn Abbott,Ankur Kalra et al.
Natraj Katta et al.
Aortic stenosis and coronary artery disease (CAD) frequently co-exist, as they share a common pathophysiology and risk factors. Due to lack of randomised controlled trials (RCTs) and exclusion of significant CAD in transcatheter aortic valv...
A Rare Case of Cor Triatriatum Sinister in Adulthood with Atypical Manifestation [0.03%]
成人冠状窦侧三房心的罕见病例报告及不典型表现分析
Thauler Alves de Oliveira,Renan Attílio Santos Marquiori
Thauler Alves de Oliveira
A 47-year-old man was admitted to the Santa Casa de Misericórdia Hospital in Belo Horizonte, Brazil, with recurrent signs and symptoms of tachycardia, palpitation and fatigue. During medical examination, an electrocardiogram and 24-hour Ho...
Cardiovascular Effects of COVID-19 - What Do We Know and Where Should We Go? [0.03%]
新冠肺炎的心血管影响：我们了解多少？未来研究方向何在？
Matthew Ryan,Ozan Demir,Kevin O&#x;Gallagher et al.
Matthew Ryan et al.
Amongst the many challenges of the global pandemic, understanding the effects of coronavirus disease 2019 (COVID-19) on the cardiovascular system has emerged as a key priority. Emerging data indicate possible roles for cardiac biomarkers an...